Webinar: NYC Prostate Cancer Virtual Mini Summit Series by Weill Cornell Medicine

Weill Cornell Medicine

About This Series

Over 2.9 million men in the United States have been diagnosed or are living with prostate cancer. While the pandemic has prevented us from coming together in-person for our annual educational event, we are proud to offer a virtual #NYCProstateSummit. This four-part webinar series provides important information for prostate cancer patients and loved ones, as well as unparalleled access to the field’s foremost experts.

An outgrowth of the Prostate Cancer Clinical Trials Consortium (PCCTC), the NYC Prostate Cancer Summit launched in 2018 and the Annual NYC Prostate Cancer Summit is hosted by Weill Cornell Medicine, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center and Memorial Sloan Kettering Cancer Center.

Register today!

Meet The Hosts

David Nanus, MD

Dr. David Nanus is an internationally recognized leader in the treatment and care of patients with genitourinary (GU) cancers, including cancers of the prostate, kidney, bladder and testes. He is actively involved in clinical, translational and basic research in GU malignancies, serving as principle or co-investigator on a variety of clinical research trials that incorporate novel targeted therapies for his patients. Dr. Nanus is Director of the NewYork-Presbyterian and Weill Cornell Medicine Healthcare Services Cancer Program, a program unifying oncology and hematology clinical care and research at NewYork-Presbyterian’s regional hospitals. He previously served as Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian.
Susan Slovin, MD, PhD

Dr. Susan Slovin is an Attending Physician in the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center and a Professor of Medicine at Weill Cornell Medical College. She is a board-certified medical oncologist with expertise in the areas of prostate cancer immunology and clinical trial design. A noted immunologist, she leads an initiative that focuses on the development of novel immunologic approaches for the treatment of prostate cancer. This includes assuming leadership of the Prostate Immunotherapy Group, sponsored by the Prostate Cancer Foundation, whose challenge is to develop guidelines for development of immune therapy clinical trials in prostate cancer.

Sessions in this Series

Part 1

Living with Prostate Cancer

Join leading medical experts for a discussion on living with prostate cancer. This webinar will cover topics such as coping with canc... View more
Part 2

Newly-Diagnosed: What Are My Treatment Options?

Each year, approximately 180,000 men in the U.S. receive a prostate cancer diagnosis. Detecting the presence of prostate cancer in th... View more
Part 3

Advanced Prostate Cancer Treatment Updates

Advances in therapeutics have led to improvements in both survival and quality of life for men with advanced or metastatic prostate c... View more
Part 4

Genetic Links: Family History, Precision Medicine & More

Precision medicine is changing the way physicians approach prostate cancer care, incorporating information about a patient’s inherite... View more

START SERIES

NYC Prostate Cancer Virtual Mini Summit Series

About This Series

Meet The Hosts

Get Started Now